FERTIN PHARMA A/S: Financial statements 2018
CVR: 25834844
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
FERTIN PHARMA A/S (CVR 25834844) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 812,500,000 and a net result of DKK 45,844,000 compared with DKK 106,353,000 the year before. That is a decrease of 6.4% compared with the year before. The profit margin was 5.6%. Equity in the 2018 report amounted to DKK 895,989,000. The solvency ratio was 44.7%. The company had 609 employees in the financial year.
- Revenue
- DKK 812,500,000
- Gross Profit
- DKK 121,357,000
- Profit/Loss
- DKK 45,844,000
- Equity
- DKK 895,989,000
- Total Assets
- DKK 2,004,031,000
- Employees
- 609
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 812.5M | 121.4M | 45.8M | 896M | 609 |
| 2017 | 867.7M | 208.5M | 106.4M | 770.5M | 572 |
| 2016 | 855.7M | 546.5M | 100.1M | 659.6M | 530 |
| 2015 | 800.7M | 467.8M | 64M | 560.9M | 543 |
| 2014 | 694.1M | 419.5M | 42.2M | 495M | 446 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of September 13, 2018, Frank Charles Condella Jr has joined the board of directors of FERTIN PHARMA A/S.
As of August 1, 2018, Nikhilesh Singh has left the board of directors of FERTIN PHARMA A/S.
FERTIN PHARMA A/S has published its annual report for 2017. Revenue came to DKK 867,662,000, and the net result was DKK 106,353,000.
About FERTIN PHARMA A/S
FERTIN PHARMA A/S is a Danish company of the type Aktieselskab based in Vejle, founded in 2001. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named JUT NR. 2128 A/S. The management consists of Michael Henrik Thomsen. The board consists of Christopher Beck Lambert (chair), Bo Korsgaard Jensen, Jovana Mejri and Michael Henrik Thomsen. The company is owned by Aspeya Inc.. The company has 959 employees (2026). In 2025, the company reported revenue of DKK 1,344,394,000 and a net result of DKK -280,841,000 compared with DKK -259,011,000 the year before. Equity in the 2025 report amounted to DKK 1,269,900,000.